KEY FINDINGS
The Asia-Pacific Alzheimer's disease therapeutics & diagnostics market is set to progress with a 6.89% CAGR across the forecasting period of 2022 to 2030. The rising prevalence of dementia and rapidly growing population in developing countries are driving the market growth.
MARKET INSIGHTS
The Asia-Pacific Alzheimer's disease therapeutics & diagnostics market growth estimation covers the analysis of South Korea, Thailand, Indonesia, China, India, Vietnam, Australia & New Zealand, Japan, and Rest of Asia-Pacific. The Indian healthcare system is experiencing immense progress due to the growing economy. The demand for new healthcare technological advancements in the treatment and early diagnosis of dementia and cognitive impairment is rising due to the increasing burden of Alzheimer's disease throughout the country.
Furthermore, the entire population of South Korea is rapidly aging. According to the World Population Ageing 2019 report, the population aged above 65 years or above is expected to reach 12.658 million by 2030, which was 7.715 million in 2019. The surging geriatric population is prone to neurological disorders like Alzheimer's disease and other dementias, which is expected to drive the market over the forecast period.
Additionally, according to Alzheimer's Disease International, in 2015, Alzheimer's Indonesia launched a project called Dementia Friendly Jakarta with the governor's support. In 2012, there were nearly 21 million older people, and the projected number of patients suffering from Alzheimer's is expected to reach about 5,18,000 by 2024, supplementing the growth of the Indonesia Alzheimer's disease therapeutics & diagnostics market.
COMPETITIVE INSIGHTS
Prominent companies operating in the market include Sun Pharmaceuticals Industries Ltd, GE Healthcare, Lupin Limited, Novartis AG, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market Forecast 2022-2030
Table Of Contents
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis
3.2. Key Drivers
3.2.1. Growing Geriatric Population
3.2.2. Rising Pervasiveness Of Alzheimer's Disease
3.2.3. Emerging Novel Diagnostic Technologies
3.2.4. Increasing Pipeline Drugs
3.3. Key Restraints
3.3.1. Failure Of The Late-Stage Drugs
3.3.2. Stringent Government Regulations
3.3.3. Lack Of The Availability Of Surrogate Markers
4. Key Analytics
4.1. Timeline Of Alzheimer's Disease Therapeutics & Diagnostics Market
4.2. Phases And Sternness Of Alzheimer's Disease
4.3. Impact Of Covid-19 On Alzheimer's Disease Therapeutics & Diagnostics Market
4.4. Key Market Trends
4.5. Porter's Five Forces Analysis
4.5.1. Buyers Power
4.5.2. Suppliers Power
4.5.3. Substitution
4.5.4. New Entrants
4.5.5. Industry Rivalry
4.6. Key Buying Criteria
4.7. Supply Chain Analysis
4.8. Opportunity Matrix
4.9. Vendor Landscape
5. Market By Therapeutics & Diagnostics
5.1. Therapeutics
5.1.1. Drugs
5.1.1.1. Marketed Drugs
5.1.1.2. Pipeline Drugs
5.1.2. Disease Stage
5.1.2.1. Late-Stage: Severe Ad
5.1.2.2. Early/Middle Stage: Mild To Moderate Ad
5.1.2.3. Prodromal Stage
5.1.3. Generic & Branded
5.1.3.1. Branded
5.1.3.2. Generic
5.2. Diagnostics
5.2.1. Lumbar Puncture Test
5.2.2. Positron Emission Tomography
5.2.3. Electroencephalography
5.2.4. Magnetic Resonance Imaging
5.2.5. Computed Tomography
5.2.6. Blood Test
5.2.7. Other Diagnostics
6. Geographical Analysis
6.1. Asia-Pacific
6.1.1. Market Size & Estimates
6.1.2. Key Growth Enablers
6.1.3. Key Challenges
6.1.4. Key Players
6.1.5. Country Analysis
6.1.5.1. China
6.1.5.2. Japan
6.1.5.3. India
6.1.5.4. South Korea
6.1.5.5. Indonesia
6.1.5.6. Thailand
6.1.5.7. Vietnam
6.1.5.8. Australia & New Zealand
6.1.5.9. Rest Of Asia-Pacific
7. Competitive Landscape
7.1. Key Strategic Developments
7.1.1. Mergers & Acquisitions
7.1.2. Product Launches & Developments
7.1.3. Partnerships & Agreements
7.1.4. Business Expansions, Announcements, & Divestitures
7.2. Company Profiles
7.2.1. Allergan Plc (Acquired By Abbvie)
7.2.2. Amarantus Bioscience Holdings Inc
7.2.3. Baxter International Inc
7.2.4. Biogen Inc
7.2.5. Cognoptix Inc
7.2.6. Eisai Co Ltd
7.2.7. Eli Lilly & Company
7.2.8. F Hoffmann-La Roche
7.2.9. Ge Healthcare
7.2.10. Johnson & Johnson
7.2.11. Lupin Limited
7.2.12. Merck & Co Inc
7.2.13. Novartis Ag
7.2.14. Pfizer Inc
7.2.15. Siemens Healthineers Ag
7.2.16. Sun Pharmaceuticals Industries Ltd
7.2.17. Teva Pharmaceutical Industries Limited
7.2.18. Zydus Cadila
List Of Tables
Table 1: Market Snapshot - Alzheimer's Disease Therapeutics & Diagnostics
Table 2: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Therapeutics & Diagnostics, Historical Years, 2018-2021 (In $ Million)
Table 3: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Therapeutics & Diagnostics, Forecast Years, 2022-2030 (In $ Million)
Table 4: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Drugs, Historical Years, 2018-2021 (In $ Million)
Table 5: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Drugs, Forecast Years, 2022-2030 (In $ Million)
Table 6: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Disease Stage, Historical Years, 2018-2021 (In $ Million)
Table 7: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Disease Stage, Forecast Years, 2022-2030 (In $ Million)
Table 8: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Generic & Branded, Historical Years, 2018-2021 (In $ Million)
Table 9: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Generic & Branded, Forecast Years, 2022-2030 (In $ Million)
Table 10: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Diagnostics, Historical Years, 2018-2021 (In $ Million)
Table 11: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Diagnostics, Forecast Years, 2022-2030 (In $ Million)
Table 12: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Country, Historical Years, 2018-2021 (In $ Million)
Table 13: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Country, Forecast Years, 2022-2030 (In $ Million)
Table 14: Leading Players Operating In Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market
Table 15: List Of Mergers & Acquisitions
Table 16: List Of Product Launches & Developments
Table 17: List Of Partnerships & Agreements
Table 18: List Of Business Expansions, Announcements, & Divestitures
List Of Figures
Figure 1: Pipeline Drugs Related To Alzheimer's Disease
Figure 2: Key Market Trends
Figure 3: Porter's Five Forces Analysis
Figure 4: Key Buying Criteria
Figure 5: Supply Chain Analysis
Figure 6: Opportunity Matrix
Figure 7: Vendor Landscape
Figure 8: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, Growth Potential, By Therapeutics & Diagnostics, In 2021
Figure 9: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Therapeutics, 2022-2030 (In $ Million)
Figure 10: Asia-Pacific Alzheimer's Disease Therapeutics Market, Growth Potential, By Drugs, In 2021
Figure 11: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Marketed Drugs, 2022-2030 (In $ Million)
Figure 12: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Pipeline Drugs, 2022-2030 (In $ Million)
Figure 13: Asia-Pacific Alzheimer's Disease Therapeutics Market, Growth Potential, By Disease Stage, In 2021
Figure 14: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Late-Stage: Severe Ad, 2022-2030 (In $ Million)
Figure 15: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Early/Middle Stage: Mild To Moderate Ad, 2022-2030 (In $ Million)
Figure 16: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Prodromal Stage, 2022-2030 (In $ Million)
Figure 17: Asia-Pacific Alzheimer's Disease Therapeutics Market, Growth Potential, By Generic & Branded, In 2021
Figure 18: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Branded, 2022-2030 (In $ Million)
Figure 19: Asia-Pacific Alzheimer's Disease Therapeutics Market, By Generic, 2022-2030 (In $ Million)
Figure 20: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, By Diagnostics, 2022-2030 (In $ Million)
Figure 21: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, Growth Potential, By Diagnostics, In 2021
Figure 22: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Lumbar Puncture Test, 2022-2030 (In $ Million)
Figure 23: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Positron Emission Tomography, 2022-2030 (In $ Million)
Figure 24: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Electroencephalography, 2022-2030 (In $ Million)
Figure 25: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Magnetic Resonance Imaging, 2022-2030 (In $ Million)
Figure 26: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Computed Tomography, 2022-2030 (In $ Million)
Figure 27: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Blood Test, 2022-2030 (In $ Million)
Figure 28: Asia-Pacific Alzheimer's Disease Diagnostics Market, By Other Diagnostics, 2022-2030 (In $ Million)
Figure 29: Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, Country Outlook, 2021 & 2030 (In %)
Figure 30: China Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 31: Japan Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 32: India Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 33: South Korea Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 34: Indonesia Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 35: Thailand Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 36: Vietnam Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 37: Australia & New Zealand Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Figure 38: Rest Of Asia-Pacific Alzheimer's Disease Therapeutics & Diagnostics Market, 2022-2030 (In $ Million)
Global Alzheimer's Disease Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Alzheimer's Disease Drug market size was valued at US$ 3539.3 million in 2023. With growing demand in downstream market, the Alzheimer's Disease Drug is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Alzheimer's Disease Drug market. Alzheimer's Disease Drug are expected to show stable growth in the future m......
Alzheimer's Drugs - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 97
The global Alzheimer's Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Drugs in various end use industries. The expanding demands from the Under 65 Years Old and 65 and Above 65 Years Old, are propelling Alzheimer's Drugs market. Acetylcholinesterase (AChE) Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by t......
Alzheimer Disease Drugs Industry Forecasts - China Focus
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 111
This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......
Alzheimer Disease Drugs Companies in China
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 74
This study focuses on China's Alzheimer Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......
Alzheimer Disease Drugs Markets in China
Published: 27-Nov-2023 Price: US 4000 Onwards Pages: 239
China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacit......
Global Alzheimer's Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Sep-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Alzheimer's Disease Drug market:
According to our latest research, the global Alzheimer's Disease Drug market looks promising in the next 5 years. As of 2022, the global Alzheimer's Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and,......
Global Dementia and Movement Disorder Treatment Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 110
Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market
The global Dementia and Movement......
Global Nicergoline Market Insights, Forecast to 2029
Published: 04-Jul-2023 Price: US 4900 Onwards Pages: 112
The global Nicergoline market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR......
Global Oxiracetam Market Research Report 2023
Published: 21-Apr-2023 Price: US 2900 Onwards Pages: 69
Highlights
The global Oxiracetam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oxiracetam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
